Sex Differences in the Immunogenicity and Efficacy of Seasonal Influenza Vaccines: A Meta-analysis of Randomized Controlled Trials
Open Forum Infectious Diseases · 26.04.2024 · 11 (5)
DOI: 10.1093/ofid/ofae222 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 24.04.2024. Verfasst von Fazia Tadount und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sainte-Justine Hospital Health and Research Center, Montreal, Canada. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research.
Abstract (Originalsprache)
Background
Sex impacts individuals’ response to vaccination. However, most vaccine studies do not report these differences disaggregated by sex. The aim of this study was to assess sex differences in the immunogenicity and efficacy of influenza vaccine.
Methods
We performed a meta-analysis using phase 3 randomized controlled trial data conducted between 2010 and 2018. Using hemagglutination inhibition antibody titers for each strain, differences in geometric mean ratios (GMRs) were calculated by sex. Risk ratios (RRs) comparing seroconversion proportions were pooled for females and males using random-effects models. Vaccine efficacy (VE) was assessed. Data were analyzed by age group (18–64 vs ≥65 years).
Results
A total of 33 092 healthy adults from 19 studies were included for immunogenicity analysis, and 6740 from 1 study for VE. Whereas no sex differences in immunogenicity were found in adults <65 years old, older females had a significantly greater chance to seroconvert compared to older males for all strains: RRH1N1 = 1.17 [95% confidence interval {CI}, 1.12–1.23]; RRH3N2 = 1.09 [95% CI, 1.05–1.14]; RRVictoria = 1.23 [95% CI, 1.14–1.31]; RRYamagata = 1.22 [95% CI, 1.14–1.30]. GMRs were also higher in older females for all strains compared to older males. VE in preventing laboratory-confirmed influenza was higher in older females compared to older males with VEs of 27.32% (95% CI, 1.15%–46.56%) and 6.06% (95% CI, −37.68% to 35.90%), respectively.
Conclusions
Our results suggest a higher immunogenicity and VE in females compared to males in older adults. These differences in immunogenicity and VE support the disaggregation of vaccine data by sex in clinical trials and observational studies. Clinical Trials Registration CRD42018112260.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sainte-Justine Hospital Health and Research Center, Montreal, Canada.
- Département de Microbiologie, infectiologie et immunologie, Faculté de médecine, Université de Montréal, Montreal, Canada.
- Institut national de santé publique du Québec, Québec, Canada.
- Faculty of Nursing and School of Public Health, University of Alberta, Edmonton, Canada.
- Faculty of Nursing and Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.
- Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, Canada.
ORCID-Profile: Caroline Quach
Förderung
- Canadian Institutes of Health Research
Zitieren
APA
Tadount, F., Kiely, M., Assi, A., Rafferty, E., Sadarangani, M., MacDonald, S. E., & Quach, C. (2024). Sex Differences in the Immunogenicity and Efficacy of Seasonal Influenza Vaccines: A Meta-analysis of Randomized Controlled Trials. Open Forum Infectious Diseases, 11(5). https://doi.org/10.1093/ofid/ofae222
Vancouver
Tadount F, Kiely M, Assi A, Rafferty E, Sadarangani M, MacDonald SE, et al. Sex Differences in the Immunogenicity and Efficacy of Seasonal Influenza Vaccines: A Meta-analysis of Randomized Controlled Trials. Open Forum Infectious Diseases. 2024;11(5). doi:10.1093/ofid/ofae222
BibTeX
@article{Tadount2024,
author = {Tadount, Fazia and Kiely, Marilou and Assi, Ali and Rafferty, Ellen and Sadarangani, Manish and MacDonald, Shannon E and Quach, Caroline},
title = {Sex Differences in the Immunogenicity and Efficacy of Seasonal Influenza Vaccines: A Meta-analysis of Randomized Controlled Trials},
journal = {Open Forum Infectious Diseases},
year = {2024},
volume = {11},
number = {5},
doi = {10.1093/ofid/ofae222}
}
EUVIMED